Shuichi Kusano

Molecular‐Size Reduction of a Potent CXCR4‐Chemokine Antagonist Using Orthogonal Combination of Conformation‐ and Sequence‐Based Libraries

Nobutaka Fujii, Shinya Oishi, Kenichi Hiramatsu et al. · Angewandte Chemie International Edition · 2003 · 202 citations

Peptide Engineering, Molecular Biology, Peptide Science +17

Promoter Selectivity of Escherichia coli RNA Polymerase Eσ70 and Eσ38 Holoenzymes

Shuichi Kusano, Quinquan Ding, Nobuyuki Fujita et al. · Journal of Biological Chemistry · 1996 · 189 citations · Full text

Selectivity of the<i>Escherichia coli</i>RNA polymerase Eσ³⁸for overlapping promoters and ability to support CRP activation

Annie Kolb, Denise Kotlarz, Shuichi Kusano et al. · Nucleic Acids Research · 1995 · 126 citations · Full text

Antidiabetic Activity of White Skinned Sweet Potato(Ipomoea batatas L.) in Obese Zucker Fatty Rats.

Shuichi Kusano, Hiroyuki ABE · Biological and Pharmaceutical Bulletin · 2000 · 107 citations · Full text

Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonistsElectronic supplementary information (ESI) available: Fig. S1: behaviors of TF14013, TF14016 and TF14013-Me in mouse serum; Fig. S2: behaviors of TF14002 (a), TF14005 (b), TF14006 (c), TF14013 (d), TF14016 (e) and TF14013 analogs (f) in rat liver homogenate; Table S1: characterization data of novel synthetic peptides; and HPLC charts for synthetic compounds of 4F-benzoyl-TE14011 (TF14013), 4F-benzoyl-TN14003 (TF14016), nicotinoyl-TE14011 (TF14031) and 4F-benzoyl-TE14011-Me (TF14013-Me), and for a degraded sample of 4F-benzoyl-TE14011 (TF14013) in rat liver homogenate and its co-injection with an authentic compound des-[Arg14-NH2]-4F-benzoyl-TE14011. See http://www.rsc.org/suppdata/ob/b3/b306613b/

Hirokazu Tamamura, Kenichi Hiramatsu, Makiko Mizumoto et al. · Organic & Biomolecular Chemistry · 2003 · 95 citations